Comparison of Buserelin to Danazol Therapy in Endometriosis
Although the etiology of endometriosis is not understood, it is known that the ectopic endometrial tissue is sensitive to the production of sex steroid hormones during the menstrual cycle. Endometriosis is rare before menarche and develops usually during the reproductive years. The importance of ovarian steroids in the development and maintenance of endometriosis is also demonstrated by the usual curative effect of oophorectomy and the spontaneous regression of the disease at menopause. Experimentally implanted endometriosis in castrated monkeys requires sex steroids for its maintenance .
KeywordsGnRH Agonist Serum Estradiol Serum Estradiol Level Endometriotic Tissue Clinical Side Effect
Unable to display preview. Download preview PDF.
- 5.Vihko, R, Isotalo, H, and Kauppila, A (1984). Hormonal regulation of endometrium and endometriosis tissue. In: Raynaud, JP (ed.) “Medical Management of Endometriosis”, p 79. (New York: Raven Press)Google Scholar
- 7.Kistner, RW (1959). The treatment of endometriosis by inducing pseudopregnancy with ovarian hormones: a report of 58 cases. Fertil Steril, 10, 539Google Scholar
- 9.Barbieri, RL, Evans, S, and Kistner, RW (1982). Danazol in the treatment of endometriosis: analysis of of 100 cases with a 4-year follow-up. Fertil Steril, 36, 737Google Scholar
- 16.Zorn, JR, Tanger, Ch, Roger, M, Grenier, J, Comaru-Schally, AM, and Schally, AV (1986). Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: A preliminary study in eight women with endometriosis. Int J Fertil, 3, 11Google Scholar
- 19.Lemay, A, Maheux, R, Huot, C, Blanchet, J, and Faure, N (1988). Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis. Am J Obstet Gynecol (in press)Google Scholar
- 20.American Fertility Society (1979). Classification of endometriosis. Fertil Steril, 32, 633Google Scholar
- 27.Cann, CE, Henzl, M, Burry, K, Andreko, J, Hanson, F, Adamson, D, Trobough, G, and Strewler, G (1986). Reversible bone loss is induced by GnRH agonist. 68th Annual Meeting of the Endocrine Society, Anaheim, California, AbstractGoogle Scholar